Tolremo Therapeutics

Developing anti-cancer small molecules targeting novel drug resistance pathways

placeZurich, Zurich, Switzerland calendar_todayFounded 2017 groups16 employees language tolremo.com

Registered entities

Social engagement

Social engagement: 6.2K social following, 4 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include BioMedPartners, Altos Ventures Management.

Investor typeCountShare
Venture capital545%
Angel & family office19%
Accelerator & incubator327%
Other / undisclosed218%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

6 May 2026 · Clinical Trial Manager Oncology · Basel

Based on job postings tracked across public sources.

Recent activity

30 Oct 2025
Leadership hire
Scientific Advisory Board (SAB)
17 Oct 2025
Event
ESMO 2025
Coming soon